• Olsalazine Sodium: Applied Workflows in Tumor and Transporte

  2026-06-11

  Olsalazine Sodium, a precision mesalamine dimer, empowers researchers to dissect inflammation and tumor biology with reproducible, high-impact workflows. Its dual role as a potent LTB4 chemotaxis inhibitor and tool for xenobiotic transporter studies uniquely positions it for translational cancer and vector biology research.

• Deciphering Metabolite Regulation of TET2 via Biochemical an

  2026-06-11

  This study introduces a rigorous protocol combining biochemical assays and STD NMR spectroscopy to reveal how metabolic cofactors and inhibitors modulate the activity of human TET2 dioxygenase. The approach enables systematic identification of both activators and inhibitors, advancing our understanding of the metabolic-epigenetic interface and offering a template for dissecting enzyme-metabolite interactions.

• MitMAB and the Future of Endocytosis Research in Organoid Mo

  2026-06-10

  Explore how MitMAB, a potent dynamin GTPase inhibitor, is transforming endocytosis research in physiologically relevant intestinal stem cell–based organoid models. This thought-leadership article blends mechanistic insight, experimental guidance, and strategic perspective for translational researchers seeking to dissect membrane trafficking and vesicle uptake, with a focus on the implications for milk-derived extracellular vesicles (MEV) in gut biology.

• AZD0156: ATM Kinase Inhibitor for Precision DNA Damage Resea

  2026-06-10

  AZD0156 empowers cancer researchers with highly selective, potent ATM kinase inhibition, enabling reliable DNA damage response assays and combinatorial therapy investigations. Its unique impact on metabolic adaptation and checkpoint control makes it a standout tool for uncovering new therapeutic strategies and metabolic vulnerabilities in cancer models.

• Scenario-Driven Solutions with T7 RNA Polymerase (SKU K1083)

  2026-06-09

  This article addresses common laboratory challenges in RNA synthesis, gene editing, and workflow reproducibility using T7 RNA Polymerase (SKU K1083), a recombinant enzyme expressed in E. coli. Through scenario-based Q&A, we connect real-world questions with evidence-driven best practices, highlighting how SKU K1083 ensures reliable, high-yield in vitro transcription for advanced applications in biomedical research.

• Cy5 NHS ester(Et): Technical Guide for Protein Fluorescent L

  2026-06-09

  Cy5 NHS ester(Et) addresses the need for rapid, high-purity fluorescent labeling of primary amines in proteins and biomolecules for detection and imaging workflows. It is optimized for aqueous and DMSO protocols but should not be used in ethanol-based systems or for long-term storage of working solutions.

• ω-Agatoxin IVA TFA: Selective Cav2.1 Blockade for Neuroprote

  2026-06-08

  ω-Agatoxin IVA TFA is a highly selective P/Q-type (Cav2.1) calcium channel blocker with nanomolar potency. It inhibits neurotransmitter release, demonstrates neuroprotective effects in epilepsy models, and is supplied by APExBIO for advanced neuronal research.

• Bestatin Hydrochloride: Redefining Tumor and Neuropeptide Re

  2026-06-08

  Bestatin hydrochloride (Ubenimex) is transforming translational research by bridging angiogenesis inhibition and neuropeptide signaling. This article delivers mechanistic insights, critical validation, and practical guidance, empowering researchers to unlock new frontiers in cancer and neuroscience applications.

• Perospirone (SM-9018 Freebase): Novel Ion Channel Insights f

  2026-06-07

  Explore the multifaceted role of Perospirone (SM-9018 free base) in neuropsychiatric and cardiovascular research, including its unique Kv1.5 channel inhibition and advanced assay implications. This article provides fresh, evidence-based perspectives and practical protocol guidance for scientists.

• 3-Aminobenzamide (PARP-IN-1): Redefining Innate Immune Modul

  2026-06-06

  Explore how 3-Aminobenzamide, a potent PARP inhibitor, reveals novel insights into innate immune regulation and antiviral research. This article uniquely integrates molecular mechanisms with translational assay design, providing a fresh perspective beyond standard PARP inhibition workflows.

• AZD0156: Unlocking Metabolic Vulnerabilities via ATM Inhibit

  2026-06-05

  Explore how AZD0156, a potent ATM kinase inhibitor, reveals novel metabolic vulnerabilities in cancer cells. This in-depth article analyzes its mechanism, unique synergy with metabolic drugs, and practical guidance for research labs.

• Applied Insights: Pertussis Toxin for Immune Modulation Stud

  2026-06-05

  Pertussis toxin, an AB5-type protein exotoxin, is an indispensable tool for dissecting immune response modulation and signal transduction in vitro and in vivo. This article guides researchers through practical workflows, protocol optimization, and troubleshooting strategies, with insights from recent advances in TH17 lineage research.

• Gut Microbiota Absence Alters RPE/Choroid Transcriptome in A

  2026-06-04

  This study demonstrates that the absence of gut microbiota significantly changes the transcriptomic profile of the retinal pigment epithelium (RPE) and choroid, impacting pathways implicated in age-related macular degeneration (AMD) and resulting in reduced choroidal neovascularization. These findings provide new evidence for a gut–retina axis and highlight the importance of microbiome status in AMD pathobiology and retinal disease modeling.

• KU-60019: ATM Kinase Inhibitor for Glioma Migration and Radi

  2026-06-04

  Explore how the potent ATM kinase inhibitor KU-60019 uniquely disrupts glioma cell migration and enhances radiosensitization. This article provides advanced mechanistic insight and practical guidance beyond standard DNA damage response research.

• LC-Thalamic Reticular Pathway in Chronic Pain and Attention

  2026-06-03

  This study delineates the role of the locus coeruleus (LC) to thalamic reticular nucleus (TRN) pathway in the comorbidity of chronic pain and attention deficit-like behaviors. By integrating chemogenetics, optogenetics, tracing, and electrophysiology, the work uncovers a previously uncharacterized circuit critical for the regulation of both nociception and cognitive function, providing a mechanistic substrate for their clinical overlap.

681 records 9/46 page Previous Next First page 上5页 678910 下5页 Last page